Assigning backbone NMR resonances for full length tau isoforms: Efficient compromise between manual assignments and reduced dimensionality

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Harbison, Nicholas W ^a   Bhattacharya, Shibani ^b   Eliezer, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK STRUCTURAL BIOLOGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PEPTIDE FRAGMENT; TAU K19 PROTEIN; TAU PROTEIN; TAU352 PROTEIN; TAU441 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CONTROLLED STUDY; FOURIER TRANSFORMATION; G MATRIX FOURIER TRANSFORMATION; MATHEMATICAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN PURIFICATION; PROTEIN STRUCTURE; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN ISOFORMS; TAU PROTEINS;

EID: 84859979252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034679     Document Type: Article

References (47)

1. Cleveland DW, Hwo SY, Kirschner MW, (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116: 207-225.
2. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA, (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526.
3. Wei ML, Andreadis A, (1998) Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J Neurochem 70: 1346-1356.
4. Cleveland DW, Hwo SY, Kirschner MW, (1977) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116: 227-247.
5. Binder LI, Frankfurter A, Rebhun LI, (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378.
6. Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, et al. (1992) Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci USA 89: 4378-4381.
7. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI, (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci USA 92: 10369-10373.
8. Jenkins SM, Johnson GV, (1998) Tau complexes with phospholipase C-gamma in situ. Neuroreport 9: 67-71.
9. Brandt R, Léger J, Lee G, (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131: 1327-1340.
10. Wagner U, Utton M, Gallo JM, Miller CC, (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci 109 (Pt 6): 1537-1543.
11. Landrieu I, Lacosse L, Leroy A, Wieruszeski J-M, Trivelli X, et al. (2006) NMR analysis of a Tau phosphorylation pattern. J Am Chem Soc 128: 3575-3583 doi:10.1021/ja054656.
12. Leroy A, Landrieu I, Huvent I, Legrand D, Codeville B, et al. (2010) Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J Biol Chem 285: 33435-33444 doi:10.1074/jbc.M110.149419.
13. Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E, (1997) MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89: 297-308.
14. Garcia ML, Cleveland DW, (2001) Going new places using an old MAP: tau, microtubules and human neurodegenerative disease. Curr Opin Cell Biol 13: 41-48.
15. Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, et al. (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85: 4884-4888.
16. Ksiezak-Reding H, Yen SH, (1991) Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for self-association. Neuron 6: 717-728.
17. Ingram EM, Spillantini MG, (2002) Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol Med 8: 555-562.
18. Goedert M, Ghetti B, Spillantini MG, (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process. Ann N Y Acad Sci 920: 74-83.
19. Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E, (1994) Domains of tau protein and interactions with microtubules. Biochemistry 33: 9511-9522.
20. Eliezer D, (2009) Biophysical characterization of intrinsically disordered proteins. Curr Opin Struct Biol 19: 23-30 doi:10.1016/j.sbi.2008.12.004.
21. Dyson HJ, Wright PE, (1998) Equilibrium NMR studies of unfolded and partially folded proteins. Nat Struct Biol 5 (Suppl): 499-503 doi:10.1038/739.
22. Eliezer D, Barré P, Kobaslija M, Chan D, Li X, et al. (2005) Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation. Biochemistry 44: 1026-1036 doi:10.1021/bi048953n.
23. Jeganathan S, Bergen von M, Brutlach H, Steinhoff H-J, Mandelkow E, (2006) Global hairpin folding of tau in solution. Biochemistry 45: 2283-2293 doi:10.1021/bi0521543.
24. Barré P, Eliezer D, (2006) Folding of the repeat domain of tau upon binding to lipid surfaces. J Mol Biol 362: 312-326 doi:10.1016/j.jmb.2006.07.018.
25. Peterson DW, Zhou H, Dahlquist FW, Lew J, (2008) A soluble oligomer of tau associated with fiber formation analyzed by NMR. Biochemistry 47: 7393-7404 doi:10.1021/bi702466a.
26. Mukrasch MD, Bergen von M, Biernat J, Fischer D, Griesinger C, et al. (2007) The "jaws" of the tau-microtubule interaction. J Biol Chem 282: 12230-12239 doi:10.1074/jbc.M607159200.
27. Sillen A, Barbier P, Landrieu I, Lefebvre S, Wieruszeski J-M, et al. (2007) NMR investigation of the interaction between the neuronal protein tau and the microtubules. Biochemistry 46: 3055-3064 doi:10.1021/bi061920i.
28. Landrieu I, Leroy A, Smet-Nocca C, Huvent I, Amniai L, et al. (2010) NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. Biochem Soc Trans 38: 1006-1011 doi:10.1042/BST0381006.
29. Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, et al. (2009) Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol 7: e34 doi:10.1371/journal.pbio.1000034.
30. Smet C, Leroy A, Sillen A, Wieruszeski J-M, Landrieu I, et al. (2004) Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein. Chembiochem 5: 1639-1646 doi:10.1002/cbic.200400145.
31. Lippens G, Sillen A, Smet C, Wieruszeski J-M, Leroy A, et al. (2006) Studying the natively unfolded neuronal Tau protein by solution NMR spectroscopy. Protein Pept Lett 13: 235-246.
32. Narayanan RL, Dürr UHN, Bibow S, Biernat J, Mandelkow E, et al. (2010) Automatic assignment of the intrinsically disordered protein Tau with 441-residues. J Am Chem Soc 132: 11906-11907 doi:10.1021/ja105657f.
33. Kim S, Szyperski T, (2003) GFT NMR, a new approach to rapidly obtain precise high-dimensional NMR spectral information. J Am Chem Soc 125: 1385-1393 doi:10.1021/ja028197d.
34. Szyperski T, Atreya HS, (2006) Principles and applications of GFT projection NMR spectroscopy. Magn Reson Chem 44 Spec No: S51-60 doi:10.1002/mrc.1817.
35. Atreya HS, Szyperski T, (2004) G-matrix Fourier transform NMR spectroscopy for complete protein resonance assignment. Proc Natl Acad Sci USA 101: 9642-9647 doi:10.1073/pnas.0403529101.
36. Xia Y, Zhu G, Veeraraghavan S, Gao X, (2004) (3,2)D GFT-NMR experiments for fast data collection from proteins. J Biomol NMR 29: 467-476 doi:10.1023/B:JNMR.0000034352.75619.3f.
37. Atreya HS, Eletsky A, Szyperski T, (2005) Resonance assignment of proteins with high shift degeneracy based on 5D spectral information encoded in G2FT NMR experiments. J Am Chem Soc 127: 4554-4555 doi:10.1021/ja042562e.
38. Cavanagh J, (2007) Protein NMR spectroscopy. Academic Pr.
39. Weisemann R, Rüterjans H, Bermel W, (1993) 3D triple-resonance NMR techniques for the sequential assignment of NH and 15N resonances in 15N- and 13C-labelled proteins. J Biomol NMR 3: 113-120.
40. Freuh D, Sun Z, Vosburg D, Walsh C, Hoch J, et al. (2006) Non-uniformly sampled double-TROSY hNcaNH experiments for NMR sequential assignments of large proteins. phi7AJ Am Chem Soc 128: 5757-5763.
41. Wüthrich K, (1986) NMR of proteins and nucleic acids. Wiley-Interscience.
42. Wishart DS, Case DA, (2001) Use of chemical shifts in macromolecular structure determination. Meth Enzymol 338: 3-34.
43. Bergen von M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, et al. (2000) Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proc Natl Acad Sci USA 97: 5129-5134.
44. Sibille N, Huvent I, Fauquant C, Verdegem D, Amniai L, et al. (2011) Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein. Proteins doi:10.1002/prot.23210.
45. Fauquant C, Redeker V, Landrieu I, Wieruszeski J-M, Verdegem D, et al. (2011) Systematic identification of tubulin-interacting fragments of the microtubule-associated protein Tau leads to a highly efficient promoter of microtubule assembly. J Biol Chem 286: 33358-33368 doi:10.1074/jbc.M111.223545.
46. Bibow S, Ozenne V, Biernat J, Blackledge M, Mandelkow E, et al. (2011) Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau. J Am Chem Soc 133: 15842-15845 doi:10.1021/ja205836j.
47. Bibow S, Mukrasch MD, Chinnathambi S, Biernat J, Griesinger C, et al. (2011) The dynamic structure of filamentous tau. Angew Chem Int Ed Engl 50: 11520-11524 doi:10.1002/anie.201105493.